Studies have found that the pathogenesis of depression and the mechanisms underlying antidepressant therapeutic action are related to the tissue plasminogen activator (tPA)/brain-derived neurotrophic factor (BDNF) lysis pathway (10). The gene discussed is BDNF; the disease is depressive symptom measurement.